文献速递生殖医学产科

高空蝶呤激素水平与多囊卵巢综合征患者早产风险相关

High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome.
PubMed 文献 · Fertil Steril · 2020-01-20

这项回顾性队列研究纳入2017年1月至2018年7月间接受体外受精的25,165个周期,探讨血清抗苗勒管激素(AMH)水平与多囊卵巢综合征(PCOS)患者早产风险的关系。结果发现,在PCOS患者中,早产者AMH水平高于足月产者(9.3 vs. 6.9 ng/mL,P<.01);AMH高于第75百分位(9.75 ng/mL)的PCOS患者早产风险增加(调整OR 4.0,95%CI 1.94-8.08),冻融胚胎移植(FET)患者中AMH高于第90百分位(10.10 ng/mL)也与早产风险增加相关(调整OR 2.0,95%CI 1.16-3.36)。

要点

  • PCOS患者中早产者AMH水平显著高于足月产者(9.3 vs. 6.9 ng/mL)。
  • PCOS患者AMH>9.75 ng/mL时早产风险增加4倍(调整OR 4.0)。
  • FET患者AMH>10.10 ng/mL时早产风险增加2倍(调整OR 2.0)。

核心结论

  • PCOS患者血清AMH高于第75百分位与早产风险增加相关。
  • FET患者血清AMH高于第90百分位与早产风险增加相关。

研究设计与样本

  • 回顾性队列研究,纳入2017年1月至2018年7月接受体外受精的25,165个周期。

主要发现

  • 整个队列中足月产与早产组血清AMH水平无差异(3.8 vs. 4.1 ng/mL,P>.05)。
  • PCOS患者中早产组AMH水平高于足月产组(9.3 vs. 6.9 ng/mL,P<.01)。
  • PCOS患者AMH高于第75百分位(9.75 ng/mL)时早产风险增加(调整P<.0001,调整OR 4.0,95%CI 1.94-8.08)。
  • FET患者AMH高于第90百分位(10.10 ng/mL)时早产风险增加(调整P<.05,调整OR 2.0,95%CI 1.16-3.36)。

临床怎么用

  • 对PCOS患者,可参考AMH水平(尤其>9.75 ng/mL)评估早产风险。
  • 对FET患者,AMH>10.10 ng/mL时需关注早产风险。

局限性

  • 回顾性队列设计可能存在残余混杂。
  • 研究限于学术生殖中心接受IVF的人群,外推性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Antimüllerian hormone (AMH) levels are higher in patients with polycystic ovary syndrome (PCOS). Accumulating evidence indicates that AMH has an impact on the physiology of the female reproductive system. OBJECTIVE: To investigate the association of AMH levels with the risk of preterm delivery in PCOS patients. DESIGN: Retrospective cohort study. SETTING: Academic fertility center. PATIENTS: Women who underwent in vitro fertilization between January 2017 and July 2018 (25,165 cycles). INTERVENTIONS: None. MAIN OUTCOME MEASURES: The primary outcome was preterm delivery. RESULTS: Serum AMH levels were not different between the term delivery and preterm delivery groups in the entire cohort (3.8 vs. 4.1 ng/mL, P>.05). In patients diagnosed with PCOS, those with preterm delivery had higher AMH levels than were found in patients with term delivery (9.3 vs. 6.9 ng/mL, P<.01). Preterm deliveries predominated in PCOS patients with AMH levels above the 75th percentile (9.75 ng/mL) (adjusted P<.0001, adjusted odds ratio [OR] 4.0, 95% confidence interval [CI] 1.94, 8.08)) and frozen-thawed embryo transfer (FET) patients with AMH levels higher than the 90th percentile (10.10 ng/mL) (adjusted P<.05, adjusted OR 2.0, 95% CI 1.16, 3.36). CONCLUSION: Serum AMH levels higher than 75th percentile were associated with an increased risk of preterm delivery in patients with PCOS, and serum AMH levels higher than the 90th percentile were associated with an increased risk of preterm delivery in FET patients.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Hu KL, Liu FT, Xu H, et al. High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome. Fertil Steril. 2020. PMID: 31973904. doi:10.1016/j.fertnstert.2019.09.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。